Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
SK Channels as a New AAD Target
Author(s): Arnela Saljic , Jordi Heijman , Dobromir Dobrev Added: 1 year ago

Electrophysiology & Arrhythmia
ACC 25: Optimizing DAPT Duration
Author(s): Hyo-Soo Kim Added: 1 year ago
ACC 25 - Findings from a stratified study investigating coronary stenting and bleeding risk suggest 3 months are the optimal duration of DAPT after PCI.Dr Hyo-Soo Kim (Seoul National University Hospital, KR) sits down to discuss the first randomized study stratifying patients receiving percutaneous coronary intervention with drug eluting stents according to bleeding risk based on the ARC HBR… View more

Anticoagulation

Intervention
ACC 2025: The ALPACA Phase 2 Trial
Author(s): Steven E Nissen Added: 1 year ago
ACC 2025 - 540-day follow up of lepodisiran in patients with elevated lipoprotein(a) (Lp(A)) shows the extended duration of action of lepodisiran will allow infrequent dosing in the ongoing cardiovascular outcome trial.Dr Steven Nissen (Cleveland Clinic, Cleveland, US) joins us onsite at ACC to discuss the ALPACA phase 2 trial (NCT05565742), investigating the safety and efficacy of lepodisiran,… View more

Prevention & Chronic Conditions
VHPSD versus Conventional Catheter Ablation in AF
Author(s): Giky Karwiky , Mohammad Iqbal , Raymond Pranata Added: 2 years ago
In this episode of the Radcliffe Podcast, we are joined by Dr Raymond Pranata, Dr Mohammad Iqbal and Dr Giky Karwiky (Hasan Sadikin General Hospital, Bandung, Indonesia) as they discuss their recently published systematic review and meta-analysis of very-high-power short-duration ablation as compared to conventional ablation for the treatment of pulmonary vein isolation in atrial fibrillation.13… View more

Electrophysiology & Arrhythmia
ESC 23: The ONCO DVT Study
Author(s): Yugo Yamashita Added: 2 years ago
ESC 23 — In this concise interview, Dr Yugo Yamashita (Kyoto University Graduate School of Medicine, JP) reveals the findings of the ONCO DVT Study (NCT03895502). The ONCO DVT study (Takeshi Morimoto) aimed to determine the ideal duration of anticoagulation therapy with the direct oral anticoagulant (DOAC) edoxaban for the treatment of isolated distal deep vein thrombosis (IDDVT) in patients… View more

Anticoagulation

Vascular Disease and Surgery
Survey on Interdisciplinary Management of Cardiotoxicity in Outpatient Sett
Author(s): Silvio Quick , Lorena Payo-Anez , Clara Marx Casimiro de Almeida , et al Added: 1 year ago

Guidelines & Statements

Imaging & Diagnostics
Resistant Hypertension: An Overview
Author(s): Giacomo Buso , Claudia Agabiti-Rosei , Matteo Lemoli , et al Added: 1 year ago

Prevention & Chronic Conditions
ESC 23: LIBerate-HeFH Study
Author(s): Frederick Raal Added: 2 years ago
ESC 23 — Prof Frederick Raal (University of the Witwatersrand, Johannesburg, SA) outlines the late-breaking results from the LIBerte-HeFH study (NCT04797104). The phase III LIBerte-HeFH study (LIB Therapeutics LLC) aimed to assess the effectiveness of PCSK9-inhibitor Ierodalcibep (LIB003) in reducing low-density lipoprotein cholesterol (LDL-C) in 300mg doses administered subcutaneously in… View more

Inherited and Congenital Cardiac Conditions

Prevention & Chronic Conditions
Unusual Presentations of Thyrotoxic Valvulopathy in Adult Thyrotoxicosis
Author(s): Andro Pramana Witarto , Bendix Samarta Witarto , Shidi Laras Pramudito , et al Added: 1 year ago

Imaging & Diagnostics

Prevention & Chronic Conditions
Ibrutinib, Venetoclax and Adverse Cardiovascular Events
Author(s): Roberta Esposito , Pierantonio Menna , Emanuela Salvatorelli , et al Added: 6 months ago

CV Disease in Special Populations

Prevention & Chronic Conditions